Three-fourths of patients with unresectable gastroesophageal cancer converted to resectable and had clear margins after treatment with a chemoimmunotherapy combination, a small Chinese study showed.

and metastases to the peritoneum from other types of cancer. Unlike many cancers that are classified into stages from 1 to 4, primary peritoneal cancer does not have an early stage. This disease ...

This understanding is crucial as it suggests that peritoneal metastases should be treated as a unique disease entity, potentially requiring tailored therapeutic strategies. In terms of treatment ...

While Stack’s early biochemistry studies were not in the cancer field, losing a family member to the disease refocused her research ... Instead, they adhere to tissues in the peritoneal cavity and ...

BRAF V600E-mutant metastatic colorectal cancer (CRC) was associated with poor clinical outcomes in patients receiving ...

Adding intraperitoneal paclitaxel to intravenous paclitaxel and oral S-1 improved survival in patients with gastric cancer and peritoneal metastasis.

Certepetide plus chemotherapy showed signs of efficacy but failed to improve progression-free survival in metastatic PDAC in the ASCEND trial.

Nelmastobart (hSTC810) combined with capecitabine therapy in metastatic colorectal cancer with resistance or intolerance to oxaliplatin and irinotecan-based chemotherapy: A phase 1b clinical trial.